Adult & adolescents->70 kg:
Initially: 40 mg/day for at least 7 days.
Maintenance: 80 mg/day.
Max: 100 mg/day.
Children & adolescents-Up to 70 kg:
Initially: 0.5 mg/kg/day for at least 7 days.
Maintenance: 1.2 mg/kg/day.
Max: 1.8 mg/kg/day.
Side Effects
Decreased appetite; headache; nausea; increased BP & heart rate; Insomnia; dry mouth in adults; Somnolence; abdominal pain; vomiting in children.
Precaution
Atomoxetine should be used with caution in patients with a history of seizures. Atomoxetine can affect heart rate and blood pressure. It is recommended that the heart rate and blood pressure be measured before treatment is started and periodically during treatment to detect possible clinically important increases. Most patients taking Atomoxetine experience a modest increase in heart rate
Interaction
Albuterol, CYP2D6 inhibitors & antihypertensive agents interact with Atomoxetine.
Pregnancy & Breastfeeding use
Pregnancy Category C. Either studies in animals have revealed adverse effects on the fetus (teratogenic or embryocidal or other) and there are no studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the fetus.
Contraindication
Hypersensitivity to Atomoxetine
Concomitant use with Monoamine oxidase inhibitors (MAOIs).
Narrow-angle glaucoma.
Severe cardiovascular or cerebrovascular disorders.
History of pheochromocytoma.
Special Warning
Pediatric use: The pharmacokinetics of Atomoxetine have not been evaluated in children under 6 years of age.
Acute Overdose
The most commonly reported gastrointestinal symptoms including somnolence, dizziness, tremor, and abnormal behaviour. Hyperactivity and agitation have also been reported. Signs and symptoms consistent with mild to moderate sympatheticnervous system activation (e.g. tachycardia, blood pressure increased, mydriasis, dry mouth) were also observed. Most events were mild to moderate. In some cases of overdose involving Atomoxetine, seizures and very rarely QT prolongation have been reported. There is limited clinical trial experience with Atomoxetine overdose. No fatal overdoses occurred in clinical trials.
Storage Condition
Store in a cool and dry place, protected from light and moisture.
Innovators Monograph
*** Taking medicines without doctor's advice can cause long-term problems.
